EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 3.0

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]

Jadwiga A Wedzicha, Amit Kiran

International Journal of Chronic Obstructive Pulmonary Disease · 2026-06 · Volume 21 · 1-3

DOI: 10.2147/copd.s631929 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026-06. Verfasst von Jadwiga A Wedzicha und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, UK. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, London, UK.
  • GSK, London, UK.

Zitieren

APA

Wedzicha, J. A., & Kiran, A. (2026). Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-3. https://doi.org/10.2147/copd.s631929

Vancouver

Wedzicha JA, Kiran A. Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-3. doi:10.2147/copd.s631929

BibTeX
@article{Wedzicha2026,
  author = {Wedzicha, Jadwiga A and Kiran, Amit},
  title = {Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  volume = {Volume 21},
  pages = {1--3},
  doi = {10.2147/copd.s631929}
}
Kostenlos starten →